The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Pfizer
Honoraria - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Hoffman-la roche ipsen; Janssen; Merck; Novartis; Pfizer
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; hoffman-la roche ipsen; Janssen; Merck; Novartis; Pfizer
Research Funding - AstraZeneca; Bayer; Janssen; Merck
Travel, Accommodations, Expenses - Janssen; Pfizer
Prognostic biomarkers and clinical outcomes in neuroendocrine prostate cancer (NEPC).
 
Richard Gagnon
No Relationships to Disclose
 
Ealia Khosh Kish
No Relationships to Disclose
 
Sarah Cook
No Relationships to Disclose
 
Kosuke Takemura
Other Relationship - The Yasuda Medical Foundation
 
Brian Yu Chieh Cheng
No Relationships to Disclose
 
Kamiko Bressler
No Relationships to Disclose
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
 
Nimira S. Alimohamed
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; EMD Serono; Merck; Pfizer; Seagen
 
Joseph D. Ruether
Honoraria - Bayer; Eisai; Eisai; Ipsen; Ipsen; Janssen Oncology; Novartis Canada Pharmaceuticals Inc; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bayer; Eisai; Ipsen; Janssen Oncology; Novartis; Pfizer; Sanofi; Sanofi
 
Richard M. Lee-Ying
Honoraria - Amgen; Janssen
Consulting or Advisory Role - Amgen; AstraZeneca Canada; Bayer; Bristol-Myers Squib; Celgene; Eisai; Ipsen; Ipsen; Janssen; Merck; Pfizer; Sanofi
Speakers' Bureau - Amgen; Celgene; Janssen
Research Funding - Sanofi
 
Pinaki Bose
Leadership - OncoHelix
Stock and Other Ownership Interests - OncoHelix
 
Michael Paul Kolinsky
Honoraria - Bayer; Janssen
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; EMD Serono; Ipsen; Janssen; Merck
Research Funding - Janssen (Inst)
 
Catalina Vasquez
No Relationships to Disclose
 
Divya Samuel
No Relationships to Disclose
 
John D Lewis
No Relationships to Disclose
 
Rehan Faridi
No Relationships to Disclose
 
Minal Borkar
No Relationships to Disclose
 
Adrian S. Fairey
No Relationships to Disclose
 
Tarek A. Bismar
Research Funding - GenomeDx (Inst)
 
Steven M. Yip
No Relationships to Disclose